It was found that 47.2% received no treatment on day of diagnosis; by one year, 71.8% were not receiving treatment.
Your search for oral corticosteroids returned 4 results
Benralizumab is an interleukin-5 receptor alpha-directed cytolytic monoclonal antibody.
Use of the affected product can potentially lead to underdosing or overdosing due to non-uniform distribution of cyclosporine.
Increased risk seen for serious infection during first 12 months of life and increased short-, long-term health outcomes.